Vaxart Cash Per Share from 2010 to 2025

VXRT Stock  USD 0.48  0.03  5.88%   
Vaxart Cash Per Share yearly trend continues to be comparatively stable with very little volatility. Cash Per Share will likely drop to 0.02 in 2025. From the period from 2010 to 2025, Vaxart Cash Per Share quarterly data regression had r-value of (0.70) and coefficient of variation of  188.44. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
0.02558802
Current Value
0.0243
Quarterly Volatility
44.37250098
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.3 M, Interest Expense of 1.9 M or Total Revenue of 27.3 M, as well as many indicators such as Price To Sales Ratio of 47.78, Dividend Yield of 0.0 or PTB Ratio of 23.85. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Vaxart Inc over the last few years. It is Vaxart's Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.02 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

Vaxart Cash Per Share Regression Statistics

Arithmetic Mean23.55
Geometric Mean2.76
Coefficient Of Variation188.44
Mean Deviation28.37
Median1.81
Standard Deviation44.37
Sample Variance1,969
Range150
R-Value(0.70)
Mean Square Error1,062
R-Squared0.50
Significance0
Slope(6.57)
Total Sum of Squares29,534

Vaxart Cash Per Share History

2025 0.0243
2024 0.0256
2023 0.27
2022 0.73
2021 1.37
2020 1.44
2019 0.63

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Cash Per Share, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Per Share 0.03  0.02 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.